Speaker illustration

Doctor Chiara Lestuzzi

ASFO Friuli Occidentale, Aviano (Italy)

Graduated cum laude at Trieste University in 1979; in Cardiology at Verona University in 1985 Since 1981 involved in studies about cardiomyopathies, pericardial diseases, cardiotoxicity of anticancer drugs, cardiac tumors. Since 1982 involved in cardio-oncology (in a dedicated Cancer Hospital part-time from 1984 and full-time since 1999) Author of >100 papers in the field of echocardiography, cardiomyopathies and cardiooncology. Organized the Meetings "Cancer and the Heart", held in 1992 and 1994 in Italy In 2017 published (by Springer) the Manual of Cardio-Oncology Member of the: Executive Committee of the Cardio-Oncology Toxicity (COT) Registry of the ESC; Board of the Italian Council of Cardiology Practice; Cardio-oncology Council of ESC; Steering and Executive Committee of the International Registry to Assess Cardiac Tumours (INTERACT);Task Force for Cardio-Oncology of ANMCO: Editorial Board of the Journal of Clinical Ultrasounds Hobbies: cross.country skying, reading

Safety of heart radiotherapy for malignant cardiac tumors: a short and long term study

Event: ESC Congress 2022

Topic: Treatment

Session: Lifetime and cardiac remodeling


Short- and long-term evaluation of safety of cardiac sarcomas radiotherapy

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Inflammatory and infiltrative cardiography


Cardiac toxicity of capecitabine: a prospective study

Event: ESC Congress 2018

Topic: Cardio-Oncology

Session: Cardio-oncology


Chemotherapeutic drugs and cardiac function. The contribution of exercise to maintain physical performance.

Event: EuroPrevent 2018

Topic: Sports Cardiology

Session: Cardiovascular consequences of drugs and substance abuse in athletes


Echocardiographic evaluation of safety of radiotherapy of cardiac sarcomas

Event: EuroEcho-Imaging 2017

Topic: Other myocardial diseases

Session: Cardiomyopathies


Incidence of capecitabine cardiac toxicity at rest and under effort: a prospective study.

Event: ESC Congress 2016

Topic: Angina pectoris unstable

Session: Blood markers in acute coronary syndrome


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb